Skip to Navigation
Skip to Main Content
Skip to Related Content
to view your mail
Yahoo Finance Plus
U.S. markets open in 3 hours 7 minutes
Russell 2000 Futures
Lannett Company, Inc. (LCI)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EST
3,603 reactions on $LCI conversation
Sign in to post a message.
received sec filing for updated employment agreements for top executives. changes made to separation due to good cause. Buy out ?
This management will happily retire in 2026
JP Morgan unloaded from 6.6% to 6.3%
LCI + AABBG GOLD-backed Ethereum tech token/ Exchange AABB + ALPP.
If TEVA and ENDP bankrupt, LCI to the moon .
With the huge decline in the share value, what is going on now is likely tax loss selling- at least that's my guess. I'll slowly accumulate at these levels knowing full well the risk / reward. Have some in the mid 3's, mid 2's and now mid single digits. No doubt it's been a disaster for longs and a great year for those that shorted. I will hold for the next 12-24 months - On a positive note, at least there has been some insider
buying lately- Very heavily insider held. GLTA D
Lannett's sales where down sharply with adderrall XR, which they marketing past three quarters. What is difference in sales going to be with current deal with Elite? Old news also news in the absence of real news?
Lannett Begins Marketing Generic Adderall® XR
Published: Mar 31, 2020
Company Has Launched Five Products in Last Three Months
PHILADELPHIA, March 31, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has commenced marketing a generic version of Adderall XR®, an extended-release mixed salt of a single entity Amphetamine capsule product (Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate), with strengths of 5 mg, 10 mg, 15 mg, 20 mg, 25 mg and 30 mg capsules. Adderall XR® and its generic versions have an estimated IQVIA market value of approximately $1.3 billion for the 12 months ending January 2020, although actual generic market values are expected to be lower.
FDA approved adderall XR on Friday for Lannett but an extension with Elite Pharma until 2024 was 8K'd today. What's up with that?
check out elite pharmaceuticals events section....agreement to have lannett market both versions of elite's Adderall extended from March 2022 for two years.
based on the on line reviews ....elite pharmaceuticals Adderall has issues
Here is the SEC filing from Elite pharma for Lannet renewal of 2 Adderall products
ELITE PHARMACEUTICALS INC /NV/ (Form: 8-K, Received: 12/02/2021 06:14:39)
Okay, I bought a whopping 200 more shares. Remember, when time isn't on your side, then timing is everything. At some point the shorts will cover. It may come at $0.10, but eventually it'll come.
Anyone have a bullish thesis for this company?
Since listing on stock exchange only couple of years around 2015 were good thanks to Favorable Levothyroxine market situation. Last few years it’s report lots of savings by integration. The stock prices tumbled from 72 to 2. They talk lots about strategy which has been destroying the company. Try to find at least one function doing well but can not. Changes required at higher levels which do not prove itself for many many years. It needs to have better vision.
Any risk of being delisted ? Serious question; not a leading question.
They going bankrupt?
Yahoo Finance Insights
Lannett Company is down 8.16% to 1.80
at such an attractive multi year low price why it's not getting acquired
The CEO needs to go!
Can this go back to 10 dollars?
For a company in the drug business that suffered so much in this pandemic it is a shame , companies that selling masks and hand cleaners saw their stock price appreciated tens if not hundreds of times while this company lost 80% or more the CEO needs to go
Amazon, Whole Foods can be sued by murderer rejected for delivery job
Apple reports blowout earnings, record revenue
Yahoo Finance Video
Elon Musk said he took his kids to Walmart to see the pandemic toilet paper shortage with his own eyes
© 2022 Yahoo. All rights reserved.
About Our Ads
Discover new investment ideas by accessing unbiased, in-depth investment research